Cellzome Inc said that it has secured a new drug discovery deal with GlaxoSmithKline under which the companies will seek to identify small-molecule drugs against epigenetic targets. Cellzome will receive €33 million upfront. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
